Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation.

Hägglund, H

Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation. [electronic resource] - Blood Dec 1998 - 4568-72 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0006-4971


Adolescent
Adult
Bone Marrow Transplantation--adverse effects
Child
Child, Preschool
Female
Hematopoietic Stem Cell Transplantation--adverse effects
Heparin--therapeutic use
Hepatic Veno-Occlusive Disease--chemically induced
Humans
Incidence
Infant
Logistic Models
Male
Middle Aged
Multivariate Analysis
Norethindrone--adverse effects
Retrospective Studies
Risk Factors
Survival Rate